Polygenic risk vectors (PRV) improve genetic risk stratification for cardio-metabolic diseases

Ruowang Li, Xinyuan Zhang, Binglan Li, Qiping Feng, Leah Kottyan, Yuan Luo, Konrad Teodor Sawicki, Atlas Khan, Nita Limdi, Megan Puckelwartz, Wei-Qi Wei, Chunhua Weng, Yong Chen, Marylyn D. Ritchie, Jason H. Moore
doi: https://doi.org/10.1101/2022.03.02.22271425

Article Information

doi 
https://doi.org/10.1101/2022.03.02.22271425
History 
  • March 11, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Ruowang Li1,
  2. Xinyuan Zhang2,
  3. Binglan Li3,
  4. Qiping Feng4,
  5. Leah Kottyan5,
  6. Yuan Luo6,
  7. Konrad Teodor Sawicki7,
  8. Atlas Khan8,
  9. Nita Limdi9,
  10. Megan Puckelwartz6,
  11. Wei-Qi Wei4,
  12. Chunhua Weng8,
  13. Yong Chen2,
  14. Marylyn D. Ritchie2 and
  15. Jason H. Moore1,*
  1. 1Cedars-Sinai Medical Center;
  2. 2University of Pennsylvania;
  3. 3Stanford University;
  4. 4Vanderbilt University;
  5. 5Cincinnati Children's Hospital;
  6. 6Northwestern University;
  7. 7Northwestern Memorial Hospital;
  8. 8Columbia University;
  9. 9University of Alabama
  1. ↵* Corresponding author; email: jason.moore{at}csmc.edu
Back to top
Posted March 11, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Polygenic risk vectors (PRV) improve genetic risk stratification for cardio-metabolic diseases
Ruowang Li, Xinyuan Zhang, Binglan Li, Qiping Feng, Leah Kottyan, Yuan Luo, Konrad Teodor Sawicki, Atlas Khan, Nita Limdi, Megan Puckelwartz, Wei-Qi Wei, Chunhua Weng, Yong Chen, Marylyn D. Ritchie, Jason H. Moore
medRxiv 2022.03.02.22271425; doi: https://doi.org/10.1101/2022.03.02.22271425
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area